What Researchers Did
Researchers reported on a single case of severe BKV-associated hemorrhagic cystitis in a hematopoietic stem cell transplant recipient that was refractory to intravenous cidofovir.
What They Found
The patient's overt hematuria successfully resolved after a few days of hyperbaric oxygen therapy combined with intravesical cidofovir instillations. Additionally, BK viruria dropped after a few weeks and remained low, suggesting a positive response to the combined treatment.
What This Means for Canadian Patients
For Canadian patients experiencing severe BKV-associated hemorrhagic cystitis refractory to standard treatments, hyperbaric oxygen therapy combined with intravesical cidofovir may represent a potential alternative treatment option. This approach could offer relief from debilitating symptoms like hematuria and reduce viral load in challenging cases.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, the findings are not generalizable to a broader patient population and require further validation through larger studies.